Hemophilia Federation America
patient advocacy organization
Based in DC
🤖
AI Overview
With $140K in lobbying spend across 36 quarterly filings, Hemophilia Federation America is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2018 to 2025.
$140K
Total Spend
8
Years Active
1
Firms Hired
7
Lobbyists Deployed
2
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $20K |
| 2019 | $20K |
| 2020 | $10K |
| 2021 | $20K |
| 2022 | $20K |
| 2023 | $50K |
| 2024 | $0 |
| 2025 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Insurance
- •The Senate side we spoke about the importance of having access to quality, affordable, meaningful healthcare coverage, which includes the protections of individuals with pre-existing conditions, conti
- •Advocated for affordable quality health care and coverage for people with bleeding disorders
- •patient protections
- •FDA funding
- •Protections for people with pre-existing conditions
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
America's Health Insurance Plans INC (Ahip)
$96.4M total spend
Guardian Life Insurance Company of America
$16.7M total spend
Ameriprise Financial, INC.
$8.5M total spend
Carefirst Bluecross Blueshield
$3.4M total spend
Liberty Partners Group O/b/o Aptqi-hschein-pds-santafe-sound-rccs-afhc-wellvana
$2.5M total spend
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.